Skip to content

Clinical trials

Completed Carcinoma, Hepatocellular trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Completed Country / region: Australia Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20094
20102
20111
20121
20134
20153
20162
20172
20183
20194
20201
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
Bristol-Myers Squibb4
Eli Lilly and Company3
Hoffmann-La Roche2
Merck Sharp & Dohme LLC2
AbbVie1
Amgen1
AstraZeneca1
Daiichi Sankyo1
Eisai Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular34
Liver Neoplasms7
Carcinoma, Non-Small-Cell Lung4
Neoplasms4
Carcinoma3
Carcinoma, Merkel Cell3
Carcinoma, Renal Cell3
Mesothelioma3
Small Cell Lung Carcinoma3
Stomach Neoplasms3

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.